Advanced search
Publication Cover
Artificial Cells, Nanomedicine, and Biotechnology
An International Journal
Volume 46, 2018 - Issue 8
Submit an article Journal homepage
1,945
Views
17
CrossRef citations to date
0
Altmetric
Articles

Development of docetaxel liposome surface modified with CD133 aptamers for lung cancer targeting

Junzhe MaDepartment of Oncology, The Second Affiliated Hospital of Soochow University, Institute of Radiotherapy & Oncology, Soochow University, Suzhou, China;
,
Huiru ZhuangDepartment of Plastic Surgery, The Second Affiliated Hospital of Soochow University, Suzhou, China
,
Zhixiang ZhuangDepartment of Oncology, The Second Affiliated Hospital of Soochow University, Institute of Radiotherapy & Oncology, Soochow University, Suzhou, China; Correspondence[email protected] [email protected]
,
Yufeng LuDepartment of Oncology, The Second Affiliated Hospital of Soochow University, Institute of Radiotherapy & Oncology, Soochow University, Suzhou, China; Correspondence[email protected] [email protected]
,
Rui XiaDepartment of Oncology, The Second Affiliated Hospital of Soochow University, Institute of Radiotherapy & Oncology, Soochow University, Suzhou, China;
,
Lei GanDepartment of Oncology, The Second Affiliated Hospital of Soochow University, Institute of Radiotherapy & Oncology, Soochow University, Suzhou, China;
&
Yuantao WuDepartment of Oncology, The Second Affiliated Hospital of Soochow University, Institute of Radiotherapy & Oncology, Soochow University, Suzhou, China;
show all
Pages 1864-1871 | Received 16 Sep 2017, Accepted 16 Oct 2017, Published online: 30 Oct 2017

Citations (17)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (6)

So-Jung Kim, Nidhi Puranik, Dhananjay Yadav, Jun-O Jin & Peter CW Lee. (2023) Lipid Nanocarrier-Based Drug Delivery Systems: Therapeutic Advances in the Treatment of Lung Cancer. International Journal of Nanomedicine 18, pages 2659-2676.
Read now
Yishuai Liu, Zixuan Zhao, Shuhui Zhu, Yumin Cheng, Jun Liu, Tiantian Ye & Shujun Wang. (2023) Docetaxel liposomes for lung targeted delivery: development and evaluation. Pharmaceutical Development and Technology 28:9, pages 856-864.
Read now
Hanieh Abbasi, Nadereh Rahbar, Maryam Kouchak, Parna Khalil Dezfuli & Somayeh Handali. (2022) Functionalized liposomes as drug nanocarriers for active targeted cancer therapy: a systematic review. Journal of Liposome Research 32:2, pages 195-210.
Read now
Qi Ma, Wei Qian, Wei Tao, Yanling Zhou & Boxin Xue. (2019) Delivery Of Curcumin Nanoliposomes Using Surface Modified With CD133 Aptamers For Prostate Cancer. Drug Design, Development and Therapy 13, pages 4021-4033.
Read now
Ishwor Poudel, Raj Ahiwale, Atmaram Pawar, Kakasaheb Mahadik & C. Bothiraja. (2018) Development of novel biotinylated chitosan-decorated docetaxel-loaded nanocochleates for breast cancer targeting. Artificial Cells, Nanomedicine, and Biotechnology 46:sup2, pages 229-240.
Read now
Imran Khan, Ashutosh Bahuguna, Monika Bhardwaj, Tejinder Pal Khaket & Sun Chul Kang. (2018) Carvacrol nanoemulsion evokes cell cycle arrest, apoptosis induction and autophagy inhibition in doxorubicin resistant-A549 cell line. Artificial Cells, Nanomedicine, and Biotechnology 46:sup1, pages 664-675.
Read now

Articles from other publishers (11)

Fatemeh Mehryab, Shahram Rabbani, Faezeh Shekari, Abdoreza Nazari, Nazanin Goshtasbi & Azadeh Haeri. (2023) Sirolimus-loaded exosomes as a promising vascular delivery system for the prevention of post-angioplasty restenosis. Drug Delivery and Translational Research.
Crossref
Horacio Eduardo Romeo & María Laura Barreiro Arcos. (2023) Clinical relevance of stem cells in lung cancer. World Journal of Stem Cells 15:6, pages 576-588.
Crossref
Sakshi Priya, Vaibhavi Meghraj Desai & Gautam Singhvi. (2022) Surface Modification of Lipid-Based Nanocarriers: A Potential Approach to Enhance Targeted Drug Delivery. ACS Omega 8:1, pages 74-86.
Crossref
Hung-Jun Lin, Tien-Li Liang, Yao-Yuan Chang, Der-Zen Liu, Jia-Yu Fan, Steve R. Roffler & Shyr-Yi Lin. (2022) Development of Irinotecan Liposome Armed with Dual-Target Anti-Epidermal Growth Factor Receptor and Anti-Fibroblast Activation Protein-Specific Antibody for Pancreatic Cancer Treatment. Pharmaceutics 14:6, pages 1202.
Crossref
Xueni Wang, Qian Zhou, Xiaoning Li, Xia Gan, Peng Liu, Xiaotao Feng, Gang Fang & Yonghong Liu. (2022) Insights into Aptamer–Drug Delivery Systems against Prostate Cancer. Molecules 27:11, pages 3446.
Crossref
Yue Zheng, Laduona Wang, Limei Yin, Zhuoran Yao, Ruizhan Tong, Jianxin Xue & You Lu. (2022) Lung Cancer Stem Cell Markers as Therapeutic Targets: An Update on Signaling Pathways and Therapies. Frontiers in Oncology 12.
Crossref
S. Aishah A. Razak, Amirah Mohd Gazzali, Faisalina Ahmad Fisol, Ibrahim M. Abdulbaqi, Thaigarajan Parumasivam, Noratiqah Mohtar & Habibah A. Wahab. (2021) Advances in Nanocarriers for Effective Delivery of Docetaxel in the Treatment of Lung Cancer: An Overview. Cancers 13:3, pages 400.
Crossref
Zhaoying Fu & Jim Xiang. (2020) Aptamer-Functionalized Nanoparticles in Targeted Delivery and Cancer Therapy. International Journal of Molecular Sciences 21:23, pages 9123.
Crossref
Marwa Labib Essa, Maged Abdeltawab El-Kemary, Eman Mohammed Ebrahem Saied, Stefano Leporatti & Nemany Abdelhamid Nemany Hanafy. (2020) Nano targeted Therapies Made of Lipids and Polymers have Promising Strategy for the Treatment of Lung Cancer. Materials 13:23, pages 5397.
Crossref
Lia Walcher, Ann-Kathrin Kistenmacher, Huizhen Suo, Reni Kitte, Sarah Dluczek, Alexander Strauß, André-René Blaudszun, Tetyana Yevsa, Stephan Fricke & Uta Kossatz-Boehlert. (2020) Cancer Stem Cells—Origins and Biomarkers: Perspectives for Targeted Personalized Therapies. Frontiers in Immunology 11.
Crossref
Hassan Dianat-Moghadam, Maryam Heidarifard, Rana Jahanban-Esfahlan, Yunes Panahi, Hamed Hamishehkar, Farhad Pouremamali, Reza Rahbarghazi & Mohammad Nouri. (2018) Cancer stem cells-emanated therapy resistance: Implications for liposomal drug delivery systems. Journal of Controlled Release 288, pages 62-83.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.